BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6166843)

  • 1. Developments in immunotherapy.
    Krakowka S
    Mod Vet Pract; 1981 Jun; 62(6):447-51. PubMed ID: 6166843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunotherapy of squamous cell carcinoma of the bovine eye and of equine sarcoid].
    Klein WR
    Tijdschr Diergeneeskd; 1990 Dec; 115(24):1149-55. PubMed ID: 2264025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy of tumors in agricultural domestic animals].
    Rutten VP; Klein WR
    Tijdschr Diergeneeskd; 1994 Dec; 119(23):726-8. PubMed ID: 7992305
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.
    Klein WR; Ruitenberg EJ; Steerenberg PA; de Jong WH; Kruizinga W; Misdorp W; Bier J; Tiesjema RH; Kreeftenberg JG; Teppema JS; Rapp HJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1095-103. PubMed ID: 6957655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of sarcomas.
    Leventhal BG
    Natl Cancer Inst Monogr; 1981 Apr; (56):183-7. PubMed ID: 6170891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The present status of BCG treatment in the veterinary practice.
    Klein WR; Rutten VP; Steerenberg PA; Ruitenberg EJ
    In Vivo; 1991; 5(6):605-8. PubMed ID: 1810446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer vaccines: current status.
    Hwang LC; Fein S; Levitsky H; Nelson WG
    Semin Oncol; 1999 Apr; 26(2):192-201. PubMed ID: 10597730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative aspects of cancer immunotherapy: immunologic methods used for treatment of spontaneous cancer in animals.
    Theilen GH; Hills D
    J Am Vet Med Assoc; 1982 Nov; 181(10):1134-41. PubMed ID: 6757216
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations on the combined systemic administration of mixed bacterial vaccine, bacillus Calmette-Guerin, transfer factor, and lymphoblastoid lymphocytes to patients with cancer, 1974-1985.
    Waisbren BA
    J Biol Response Mod; 1987 Feb; 6(1):1-19. PubMed ID: 3559626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.
    Rutten VP; Klein WR; De Jong WA; Misdorp W; Steerenberg PA; De Jong WH; Den Otter W; Ruitenberg EJ
    Cancer Immunol Immunother; 1991; 34(3):186-90. PubMed ID: 1756535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of renal cell carcinoma.
    deKernion JB
    Prog Clin Biol Res; 1984; 153():409-21. PubMed ID: 6206509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology of malignancy.
    Kaufman JR
    J Indiana State Med Assoc; 1975 Aug; 68(8):712-5. PubMed ID: 1095658
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possible applications of living BCG and the BCG cell wall in immunotherapy].
    Canti GF; Franco P; Ricci L
    Boll Ist Sieroter Milan; 1983 May; 62(2):125-9. PubMed ID: 6626318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy in genitourinary neoplasia.
    Droller MJ
    Urol Clin North Am; 1984 Nov; 11(4):643-57. PubMed ID: 6209844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
    Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y
    Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manifestations of immunotherapy in cases of bovine ocular squamous cell carcinoma.
    Heck FC; England RB
    Vet Med Small Anim Clin; 1977 Nov; 72(11):1767-73. PubMed ID: 244161
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy of experimental cancer as a guide to the treatment of human cancer.
    Rapp HJ
    Ann N Y Acad Sci; 1976; 276():550-6. PubMed ID: 1071979
    [No Abstract]   [Full Text] [Related]  

  • 20. BCG, levamisole and transfer factor in the treatment of cancer.
    Spitler LE
    Prog Exp Tumor Res; 1980; 25():178-92. PubMed ID: 6986631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.